| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.2 |